[back]
Hepatitis B
vax
Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years
Authors:
Carolyn Gallagher a;
Melody Goodman a
| Affiliation: | a Graduate Program in Public Health, Stony Brook University Medical Center, Health Sciences Center, New York, USA |
DOI:
10.1080/02772240701806501
Publication
Frequency: 8
issues per year
Published in:
Toxicological &
Environmental Chemistry,
Volume
90, Issue
5 September 2008 ,
pages 997 - 1008
Toxicological &
Environmental Chemistry,
Volume
90, Issue
5 September 2008 ,
pages 997 - 1008
Subjects:
Chemistry;
Environmental &
Ecological Toxicology;
Environmental Health;
Environmental Sciences;
Pollution;
Formats
available: HTML
(English) : PDF
(English)
Previously
published as:
Toxicological &
Environmental Chemistry
Reviews (0092-9867)
until 1980
Article Requests:
Order Reprints :
Request Permissions
View Article:
View Article (PDF)
View Article (HTML)
Abstract
This study
investigated the
association
between
vaccination with
the Hepatitis B
triple series
vaccine prior to
2000 and
developmental
disability in
children aged
1-9 years (n
= 1824), proxied
by parental
report that
their child
receives early
intervention or
special
education
services (EIS).
National Health
and Nutrition
Examination
Survey 1999-2000
data were
analyzed and
adjusted for
survey design by
Taylor
Linearization
using SAS
version 9.1
software, with
SAS callable
SUDAAN version
9.0.1. The odds
of receiving EIS
were
approximately
nine times as
great for
vaccinated boys
(n = 46)
as for
unvaccinated
boys (n =
7), after
adjustment for
confounders.
This study found
statistically
significant
evidence to
suggest that
boys in United
States who were
vaccinated with
the triple
series Hepatitis
B vaccine,
during the time
period in which
vaccines were
manufactured
with thimerosal,
were more
susceptible to
developmental
disability than
were
unvaccinated
boys.
|